fundraising
NOX
Offer Open
Noxopharm Secures $1.5M Placement and Launches SPP
Noxopharm Limited has raised $1.5 million via placement and is offering a $1 million share purchase plan to accelerate clinical programs.
November 6, 2026
Share:

Biotechnology firm Noxopharm Limited (ASX: NOX) has secured $1.5 million in a placement priced at $0.042 per share. The company is also offering eligible shareholders the opportunity to participate in a $1 million share purchase plan (SPP) at the same price to fund the development of its SOF-SKN clinical program.
Capital Raise
Biotech
ASX

